296 related articles for article (PubMed ID: 23564382)
1. Serum level of soluble (pro)renin receptor is modulated in chronic kidney disease.
Hamada K; Taniguchi Y; Shimamura Y; Inoue K; Ogata K; Ishihara M; Horino T; Fujimoto S; Ohguro T; Yoshimoto Y; Ikebe M; Yuasa K; Hoshino E; Iiyama T; Ichihara A; Terada Y
Clin Exp Nephrol; 2013 Dec; 17(6):848-56. PubMed ID: 23564382
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort.
Cho ME; Sweeney C; Fino N; Greene T; Ramkumar N; Huang Y; Ricardo AC; Shafi T; Deo R; Anderson A; Mills KT; Cheung AK;
Am J Nephrol; 2021; 52(2):141-151. PubMed ID: 33735863
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.
Shimamura Y; Hamada K; Inoue K; Ogata K; Ishihara M; Kagawa T; Inoue M; Fujimoto S; Ikebe M; Yuasa K; Yamanaka S; Sugiura T; Terada Y
Clin Exp Nephrol; 2012 Oct; 16(5):722-9. PubMed ID: 22457086
[TBL] [Abstract][Full Text] [Related]
4. Systemic factors related to soluble (pro)renin receptor in plasma of patients with proliferative diabetic retinopathy.
Hase K; Kanda A; Hirose I; Noda K; Ishida S
PLoS One; 2017; 12(12):e0189696. PubMed ID: 29240802
[TBL] [Abstract][Full Text] [Related]
5. Investigation on urinary and serum alpha klotho in dogs with chronic kidney disease.
Yi HJ; Lee JB; Lee KP; Oh YI; Song KH; Seo KW
BMC Vet Res; 2020 Jul; 16(1):246. PubMed ID: 32677951
[TBL] [Abstract][Full Text] [Related]
6. Serum soluble (pro)renin receptor levels in patients with essential hypertension.
Morimoto S; Ando T; Niiyama M; Seki Y; Yoshida N; Watanabe D; Kawakami-Mori F; Kobori H; Nishiyama A; Ichihara A
Hypertens Res; 2014 Jul; 37(7):642-8. PubMed ID: 24646643
[TBL] [Abstract][Full Text] [Related]
7. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease.
Liu Z; Zhou H; Chen X; Chen H; Wang Y; Wang T; Cai L; Hong Y; Ke H; Zheng J
Int Urol Nephrol; 2019 Mar; 51(3):503-507. PubMed ID: 30689182
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of amphiregulin in patients with chronic kidney disease.
Osakabe Y; Taniguchi Y; Hamada Ode K; Shimamura Y; Inotani S; Nishikawa H; Matsumoto T; Horino T; Fujimoto S; Terada Y
Clin Exp Nephrol; 2024 May; 28(5):421-430. PubMed ID: 38402497
[TBL] [Abstract][Full Text] [Related]
9. [EVALUATION OF CARDIOVASCULAR RISKS WITH THE USE OF MORPHOGENETIC KLOTHO PROTEIN IN PATIENTS WITH CHRONIC RENAL DISEASE].
Mukhin NA; Milovanova LY; Fomin VV; Kozlovskaya LV; Taranova MV; Androsova TV; Borisov AA
Klin Med (Mosk); 2017; 95(3):272-7. PubMed ID: 30303650
[TBL] [Abstract][Full Text] [Related]
10. Plasma s-Klotho is related to kidney function and predicts adverse renal outcomes in patients with advanced chronic kidney disease.
Liu QF; Ye JM; Yu LX; He AL; Sun Q; He DW; Li SS
J Investig Med; 2018 Mar; 66(3):669-675. PubMed ID: 29061648
[TBL] [Abstract][Full Text] [Related]
11. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
[TBL] [Abstract][Full Text] [Related]
12. The interaction between prorenin, renin and the (pro)renin receptor: time to rethink the role in hypertension.
Reudelhuber TL
Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):137-41. PubMed ID: 22240442
[TBL] [Abstract][Full Text] [Related]
13. Placental (pro)renin receptor expression and plasma soluble (pro)renin receptor levels in preeclampsia.
Narita T; Ichihara A; Matsuoka K; Takai Y; Bokuda K; Morimoto S; Itoh H; Seki H
Placenta; 2016 Jan; 37():72-8. PubMed ID: 26684753
[TBL] [Abstract][Full Text] [Related]
14. The association of plasma prorenin level with an oxidative stress marker, 8-OHdG, in nondiabetic hemodialysis patients.
Morishita Y; Hanawa S; Miki T; Sugase T; Sugaya Y; Chinda J; Iimura O; Tsunematsu S; Ishibashi K; Kusano E
Clin Exp Nephrol; 2011 Jun; 15(3):398-404. PubMed ID: 21234784
[TBL] [Abstract][Full Text] [Related]
15. Circulating α-Klotho is Related to Plasma Aldosterone and Its Follow-Up Change Predicts CKD Progression.
Qian J; Zhong J; Yan M; Cheng P; Shi H; Hao C; Gu Y; Lai L
Kidney Blood Press Res; 2018; 43(3):836-846. PubMed ID: 29843135
[TBL] [Abstract][Full Text] [Related]
16. [Association of Serum Soluble CD36 with Clinical Variables in Diabetic Patients with Chronic Kidney Diseas].
Wang YT; Guo RK; Li ZC; Zhang R; Li L; Li HY; Zhang JL; Han QQ; Liu F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 May; 49(3):414-419. PubMed ID: 30014645
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease.
Akimoto T; Yoshizawa H; Watanabe Y; Numata A; Yamazaki T; Takeshima E; Iwazu K; Komada T; Otani N; Morishita Y; Ito C; Shiizaki K; Ando Y; Muto S; Kuro-o M; Kusano E
BMC Nephrol; 2012 Nov; 13():155. PubMed ID: 23176706
[TBL] [Abstract][Full Text] [Related]
18. Soluble form of the (pro)renin receptor is augmented in the collecting duct and urine of chronic angiotensin II-dependent hypertensive rats.
Gonzalez AA; Lara LS; Luffman C; Seth DM; Prieto MC
Hypertension; 2011 Apr; 57(4):859-64. PubMed ID: 21321306
[TBL] [Abstract][Full Text] [Related]
19. Circulating α-klotho levels in CKD and relationship to progression.
Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
[TBL] [Abstract][Full Text] [Related]
20. Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism.
Yamashita K; Morimoto S; Seki Y; Watanabe D; Ichihara A
Hypertens Res; 2019 Dec; 42(12):1951-1960. PubMed ID: 31409916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
